Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0002144320-26-000003

Options or other derivatives

  • Chief Medical Officer acquired 61,783 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Oxnard Geoffrey Raymond Chief Medical Officer 2026-08-06 Grant or award · Employee Stock Option (Right to Buy) +61,783 61,783 D
Loading xslF345X06/form4-08102026_100847.xml…